These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27306302)

  • 21. Ribavirin approved with a big fat price.
    Falkenberg J
    Notes Undergr; 1998; (No 37):10-1. PubMed ID: 11365818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Campaigners challenge patent applications for hepatitis C drug in five countries.
    Bagcchi S
    BMJ; 2015 Jun; 350():h2938. PubMed ID: 26032985
    [No Abstract]   [Full Text] [Related]  

  • 23. Indian company seeks US approval for generic AIDS drugs.
    Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779
    [No Abstract]   [Full Text] [Related]  

  • 24. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia.
    Chua GN; Hassali MA; Shafie AA; Awaisu A
    Health Policy; 2010 May; 95(2-3):229-35. PubMed ID: 20044165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do patients trust the FDA?: a survey assessing how patients view the generic drug approval process.
    Kesselheim AS; Gagne JJ; Franklin JM; Eddings W; Fulchino LA; Campbell EG
    Pharmacoepidemiol Drug Saf; 2017 Jun; 26(6):694-701. PubMed ID: 28370652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generic drugs for the treatment of ocular conditions: changing the treatment landscape.
    Aref AA
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):551-3. PubMed ID: 24957466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs.
    Holmes CB; Coggin W; Jamieson D; Mihm H; Granich R; Savio P; Hope M; Ryan C; Moloney-Kitts M; Goosby EP; Dybul M
    JAMA; 2010 Jul; 304(3):313-20. PubMed ID: 20639565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmaceutical and Medical Devices: FDA Oversight.
    White RS;
    Issue Brief Health Policy Track Serv; 2015 Dec; ():1-97. PubMed ID: 27116797
    [No Abstract]   [Full Text] [Related]  

  • 29. Ukrainian health authorities adopt hepatitis C project.
    Devi S
    Lancet; 2020 Jul; 396(10246):228. PubMed ID: 32711786
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluating the bioavailability and bioequivalence of generic medications.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Jan; 48(1):13-6. PubMed ID: 20102127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What makes a generic medication generic?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2009 Dec; 47(12):17-20. PubMed ID: 20000278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trade agreements and health in developing countries.
    Stiglitz JE
    Lancet; 2009 Jan; 373(9661):363-5. PubMed ID: 19167055
    [No Abstract]   [Full Text] [Related]  

  • 33. Injectables and fillers: legal and regulatory risk management issues.
    ;
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):129S-132S. PubMed ID: 16936552
    [No Abstract]   [Full Text] [Related]  

  • 34. United States Food and Drug Administration requirements for approval of generic drug products.
    Meyer MC
    J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FDA approves new combination treatment for hepatitis C. Food and Drug Administration.
    Baker R
    BETA; 1998 Jul; ():10. PubMed ID: 11365553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Branded drug reformulation: the next brand vs. generic antitrust battleground.
    Amoresano GV
    Food Drug Law J; 2007; 62(1):249-56. PubMed ID: 17444032
    [No Abstract]   [Full Text] [Related]  

  • 37. Generic drugs in dermatology: part II.
    Payette M; Grant-Kels JM
    J Am Acad Dermatol; 2012 Mar; 66(3):353.e1-15; quiz 367-8. PubMed ID: 22342022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Access to hepatitis C medicines.
    Edwards DJ; Coppens DG; Prasad TL; Rook LA; Iyer JK
    Bull World Health Organ; 2015 Nov; 93(11):799-805. PubMed ID: 26549908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studying new drugs for HCV. Excerpts from the FDA hearing.
    Huff B
    GMHC Treat Issues; 2006; 20(8-12):11-4. PubMed ID: 17569164
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug importation and safety of drugs obtained from Canada.
    Shepherd M
    Ann Pharmacother; 2007 Jul; 41(7):1288-91. PubMed ID: 17578879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.